Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,580 | 10 | 65.5% |
| Food and Beverage | $1,509 | 24 | 17.7% |
| Consulting Fee | $1,430 | 1 | 16.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,278 | 29 | $0 (2024) |
| Madrigal Pharmaceuticals | $1,513 | 4 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $630.00 | 1 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $97.73 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,130 | 15 | Gilead Sciences, Inc. ($1,988) |
| 2023 | $422.89 | 7 | Gilead Sciences, Inc. ($422.89) |
| 2022 | $1,571 | 8 | Gilead Sciences, Inc. ($1,473) |
| 2021 | $2,395 | 5 | Gilead Sciences, Inc. ($2,395) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $89.49 | General |
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $102.41 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $42.22 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $100.08 | General |
| Category: INFLAM | ||||||
| 09/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,430.00 | General |
| 09/13/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $630.00 | General |
| Category: Rare Disease | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $121.93 | General |
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.52 | General |
| 09/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $57.24 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.77 | General |
| 05/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $58.39 | General |
| 05/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $45.17 | General |
| 01/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 11/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $84.01 | General |
| 11/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $107.49 | General |
| 11/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $99.59 | General |
| 07/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.21 | General |
| 05/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $101.47 | General |
| 04/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.87 | General |
| 02/02/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.25 | General |
| 12/07/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $460.00 | General |
| Category: HCV | ||||||
| 11/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $89.63 | General |
| 08/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 59 | $19,700 | $4,616 |
| 2022 | 3 | 73 | 97 | $27,516 | $6,451 |
| 2021 | 3 | 65 | 74 | $16,057 | $4,962 |
| 2020 | 5 | 80 | 90 | $21,819 | $5,427 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 44 | $13,640 | $3,060 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,060 | $1,556 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 50 | $15,150 | $3,858 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 36 | $7,740 | $1,594 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,626 | $1,000 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 41 | $6,232 | $1,969 | 31.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,685 | $1,661 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 18 | $4,140 | $1,331 | 32.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $7,394 | $1,800 | 24.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 16 | $3,785 | $1,096 | 29.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 23 | $3,455 | $1,026 | 29.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 22 | $4,950 | $874.05 | 17.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 15 | $2,235 | $630.23 | 28.2% |
About Dawn Drazek, NP
Dawn Drazek, NP is a Nurse Practitioner healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1710396841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Drazek, NP has received a total of $8,519 in payments from pharmaceutical and medical device companies, with $4,130 received in 2024. These payments were reported across 35 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,580).
As a Medicare-enrolled provider, Drazek has provided services to 267 Medicare beneficiaries, totaling 320 services with total Medicare billing of $21,456. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Greensboro, NC
- Active Since 08/02/2014
- Last Updated 07/15/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1710396841
Products in Payments
- Epclusa (Drug) $2,680
- REZDIFFRA (Drug) $1,350
- IQIRVO (Drug) $630.00
- RESMETIROM (Drug) $162.80
- Livdelzi (Drug) $100.08
- OCALIVA (Drug) $97.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Greensboro
Amber Seiler
Nurse Practitioner — Payments: $54,881
Eboni Farmer, Fnp, FNP
Nurse Practitioner — Payments: $9,047
Janece Moore, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $8,166
Amy Lomax, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $6,417
Ko Kim, Np, NP
Nurse Practitioner — Payments: $5,081
Sarah Slack, Dnp-Agnp, DNP-AGNP
Nurse Practitioner — Payments: $5,079